Two University of Brighton scientists are joining a pop-up stand in Brighton’s Churchill Square shopping centre on Friday (1 Feb) as part of events to mark next Monday’s (4 Feb) World Cancer Day.
Marta Falcinelli, PhD researcher in the University’s School of Pharmacy and Biomolecular Sciences (PABS), is passionate about fighting the disease and will be talking to members of the public at the Cancer Research UK (CRUK) event.
Marta joined the University’s Stress & Cancer group in 2016, fulfilling her ambition: “I have always been intrigued by science and at university I started to be very interested in molecular biology and scientific investigation, dreaming to perform experiments and work in a lab.
University of Brighton researchers are joining forces with entrepreneurs and community groups to turn Brighton and Hove into a focal point for health interventions.
The social and commercial network in the Brighton and Hove area will be tasked with improving health, accelerating innovation and enhancing competitiveness.
The University’s Healthy Futures will be the platform for new partnerships which will search for and research new disease preventions, diagnoses, pioneering treatments and breakthrough innovations. The collaborations will also foster high-skill training and jobs.
Professor Matteo Santin, Academic Lead for Healthy Futures, said: “We believe that in the long term the city has the potential to emerge as a model city for health enterprise where societal needs are addressed through pioneering approaches and where organisations thrive through public and private investment.
“As a non-profit organisation with a multidisciplinary expertise, our University is in a privileged position to make this happen.”
The academic/business partnerships will first listen to their respective needs and to those of the public. To this end, local companies, entrepreneurs and organisations are being invited to the inaugural Health Entrepreneurs’ Brunch at the Old Ship Hotel in Brighton on 19 December. Two similar events will be held at later dates. Read More →
University of Brighton scientists and partners in Vietnam have made a breakthrough in the delivery of a disease-fighting constituent of the spice turmeric.
Curcumin, extracted from turmeric, has anti-oxidant and anti-inflammatory activities and has been used for the prevention and treatment of cancer, diabetes, neurodegeneration and cardiovascular disease; all diseases linked to ageing. The problem has been finding an effective way of delivering curcumin – but now scientists believe they have found a process that does. Read More →
The university’s School of Pharmacy and Biomolecular Science (PABS) has received a Silver Award from Advance HE’s highly-regarded SWAN Charter, which promotes gender equality in the representation, progression and success of staff and students in Higher Education.
The Silver Award was granted in recognition of actions implemented to advance careers of women in science over the past few years. Read More →
It consists of a dual-screen display that generates real-time digital ‘lifeforms’ from interactions and local data. The design evolves as the data shifts, with the ‘lifeforms’ changing shape and movement. Read More →
University of Brighton scientists have discovered a more environmentally-friendly way of preventing man-made toxins from leaching into the water system – using living organisms.
Polychlorinated biphenyls (PCBs), now banned by most countries including the UK (1981), are still posing serious health risks and are suspected of causing the death of a new-born orca which made headlines around the world earlier this year when its mother Tahlequah carried the dead calf for 17 days.
Science could be on the brink of fulfilling humans’ dream of longer healthier lives, according to a University of Brighton expert on ageing.
Professor Richard Faragher, the university’s Professor of Biogerontology, will discuss the latest research findings from diet and exercise to the medicines of tomorrow at a New Scientist Live event on 20 September.
Professor Faragher, from the university’s School of Pharmacy and Biomolecular Sciences, holds the Chair of Biogerontology and is president-elect of the American Aging Association. He was the first British citizen to be elected to the Board of Directors of the American Federation for Aging Research, the leading US non-profit organisation supporting and advancing healthy aging through biomedical research, and he has been Chair of the British Society for Research on Ageing and the International Association of Biomedical Gerontology.